Search research articles
Contact Us
Filters
Showing results (351-360 of 364) with videos related to
Page
of 37
Sort By:
JMIR Public Health and Surveillance
|
April 3, 2024
Postpandemic Sentinel Surveillance of Respiratory Diseases in the Context of the World Health Organization Mosaic Framework: Protocol for a Development and Evaluation Study Involving the English Primary Care Network 2023-2024
Xinchun Gu, Conall Watson, Utkarsh Agrawal, et al.
Nature
|
August 1, 2019
Publisher Correction: The metabolite BH4 controls T cell proliferation in autoimmunity and cancer
Shane J F Cronin, Corey Seehus, Adelheid Weidinger, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
July 10, 2020
Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020
Lasse S Vestergaard, Jens Nielsen, Lukas Richter, et al.
Biorxiv : the Preprint Server for Biology
|
May 22, 2023
Crucial neuroprotective roles of the metabolite BH4 in dopaminergic neurons
Shane J F Cronin, Weonjin Yu, Ashley Hale, et al.
American Journal of Epidemiology
|
November 17, 2025
Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study
Esther Kissling, Baltazar Nunes, Mariëtte Hooiveld, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
April 12, 2024
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024
Sarah K Nørgaard, Jens Nielsen, Anne Christine Nordholm, et al.
Nature Communications
|
January 15, 2026
Excess mortality in Europe estimated by EuroMOMO during the COVID-19 pandemic and previous influenza seasons
Sarah K Nørgaard, Jens Nielsen, Christel B Schjørring, et al.
The Journal of Infection
|
August 9, 2025
Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial
Leila Janani, Alasdair P S Munro, Annie Wright, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
January 15, 2021
Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020
Sarah K Nørgaard, Lasse S Vestergaard, Jens Nielsen, et al.
The Lancet. Infectious Diseases
|
May 13, 2022
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial
Alasdair P S Munro, Shuo Feng, Leila Janani, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 364) with videos related to
Sort By:
Page
of 37
JMIR Public Health and Surveillance
|
April 3, 2024
Postpandemic Sentinel Surveillance of Respiratory Diseases in the Context of the World Health Organization Mosaic Framework: Protocol for a Development and Evaluation Study Involving the English Primary Care Network 2023-2024
Xinchun Gu, Conall Watson, Utkarsh Agrawal, et al.
Nature
|
August 1, 2019
Publisher Correction: The metabolite BH4 controls T cell proliferation in autoimmunity and cancer
Shane J F Cronin, Corey Seehus, Adelheid Weidinger, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
July 10, 2020
Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020
Lasse S Vestergaard, Jens Nielsen, Lukas Richter, et al.
Biorxiv : the Preprint Server for Biology
|
May 22, 2023
Crucial neuroprotective roles of the metabolite BH4 in dopaminergic neurons
Shane J F Cronin, Weonjin Yu, Ashley Hale, et al.
American Journal of Epidemiology
|
November 17, 2025
Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study
Esther Kissling, Baltazar Nunes, Mariëtte Hooiveld, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
April 12, 2024
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024
Sarah K Nørgaard, Jens Nielsen, Anne Christine Nordholm, et al.
Nature Communications
|
January 15, 2026
Excess mortality in Europe estimated by EuroMOMO during the COVID-19 pandemic and previous influenza seasons
Sarah K Nørgaard, Jens Nielsen, Christel B Schjørring, et al.
The Journal of Infection
|
August 9, 2025
Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial
Leila Janani, Alasdair P S Munro, Annie Wright, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
January 15, 2021
Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020
Sarah K Nørgaard, Lasse S Vestergaard, Jens Nielsen, et al.
The Lancet. Infectious Diseases
|
May 13, 2022
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial
Alasdair P S Munro, Shuo Feng, Leila Janani, et al.
Page
of 37